Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors

Autor: Stepanova, Victoria, Dergilev, Konstantin V., Holman, Kelci R., Parfyonova, Yelena V., Tsokolaeva, Zoya I., Teter, Mimi, Atochina-Vasserman, Elena N., Volgina, Alla, Zaitsev, Sergei V., Lewis, Shane P., Zabozlaev, Fedor G. **, Obraztsova, Kseniya, Krymskaya, Vera P., Cines, Douglas B.
Zdroj: In Journal of Biological Chemistry 15 December 2017 292(50):20528-20543
Databáze: ScienceDirect